Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

New guidance on the patentability of embryonic stem cell patents in Europe

The European Patent Office rules in the latest installment of the prosecution of the WARF patents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wisconsin Alumni Research Foundation, G 0002/06, 25 November, 2008.

  2. EP 0 770 125.

  3. European Directive 98/44/EC on the Legal Protection of Biotechnology Inventions.

  4. Article 53(a) of the EPC.

  5. Recital 42 of the European Directive 98/44/EC on the Legal Protection of Biotechnology Inventions.

  6. UKIPO Practice Notice: Inventions Involving Human Embryonic Stem Cells, 3 February 2009.

  7. Monsanto v. Cefetra, District Court of The Hague, 249983/HA ZA 05/2885, 19 March 2008.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fitt, R. New guidance on the patentability of embryonic stem cell patents in Europe. Nat Biotechnol 27, 338–339 (2009). https://doi.org/10.1038/nbt0409-338

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0409-338

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing